Skip to main content
. Author manuscript; available in PMC: 2017 Jul 26.
Published in final edited form as: IEEE Trans Neural Syst Rehabil Eng. 2014 Mar;22(2):389–399. doi: 10.1109/TNSRE.2013.2294904

Table 6.

Post symptom ratings (mean ± SEM) at the end of each session for the Visual Analog Scale (VAS) and Simulator Sickness Questionnaire (SSQ) for subjects in the virtual reality based therapy (VRBT) group. P-values obtained from Friedman test.

Session 1 Session 2 Session 3 Session 4 Session 5 Session 6 Session p-value
VAS
Dizziness 1.6 ± 0.4 1.1 ± 0.3 1.4 ± 0.3 0.8 ± 0.2 1.0 ± 0.3 0.5 ± 0.2 0.012
Headache 0.4 ± 0.1 0.7 ± 0.2 0.5 ± 0.2 0.4 ± 0.1 0.6 ± 0.3 0.2 ± 0.1 0.34
Nausea 0.7 ± 0.3 0.3 ± 0.2 0.6 ± 0.3 0.2 ± 0.1 0.1 ± 0.1 0.1 ± 0.04 0.062
Visual Blurring 0.9 ± 0.3 0.8 ± 0.3 0.7 ± 0.3 0.6 ± 0.2 0.5 ± 0.2 0.2 ± 0.1 0.004
SSQ
Disorientation 3.5 ± 0.5 2.6 ± 0.5 3.1 ± 0.5 2.1 ± 0.3 1.9 ± 0.3 1.7 ± 0.3 0.002
Nausea 2.3 ± 0.4 1.7 ± 0.3 2.4 ± 0.4 1.6 ± 0.3 1.8 ± 0.3 1.5 ± 0.3 0.019
Oculomotor Stress 3.9 ± 0.4 3.1 ± 0.5 3.1 ± 0.5 2.8 ± 0.5 2.4 ± 0.5 1.8 ± 0.4 0.004